Fasciculation: Clinical Trials

1 trial for Fasciculation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Fasciculation: new trials by email Literature Review of Fasciculation trials Research Report on Fasciculation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS
FLX-787-ODT - Amyotrophic Lateral Sclerosis, Fasciculation
Phase 1 / Phase 2TerminatedFlex Pharma, Inc.32018-04-052018-08-29

Narrower conditions

Amyotrophic Lateral Sclerosis (1)

Broader conditions

Central Nervous System Diseases (1)  ·  Metabolic Diseases (1)  ·  Motor Neuron Disease (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Diseases (1)  ·  Neuromuscular Manifestations (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Proteostasis Deficiencies (1)  ·  Signs and Symptoms (1)  ·  Spinal Cord Diseases (1)  ·  TDP-43 Proteinopathies (1)

Sponsors

Flex Pharma, Inc. (1)

Countries

United States (1)